AbbVie’s Acquisition of Dermal Business


Fischer Behar Chen Well Orion & Co. represented Luminera Derm Ltd. on the deal.

Luminera Derm Ltd. and its affiliated companies executed a share and asset transaction, pursuant to which Luminera sold its dermal filler portfolio and R&D pipeline to AbbVie Inc. unit Allergan Aesthetics, for a consideration of hundreds of millions of dollars.

AbbVie Inc produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, hepatitis C, women’s health, oncology, and neuroscience.

The Fischer Behar Chen Well Orion & Co. team included Raz Tepper (Picture), Sharon Klein-Manbar, Anat Shavit, Ziv Schwartz, Sharona Haim Pour, Abramovich, Yuval Peled, Ben Strauss, Hila Zackay, Ephraim Friedman, Audrey Abensur, Shaul Mizrahi and Moran Friedman

Involved fees earner: Shaul Mizrahi – Fischer & Partner; Audrey Abensur – Fischer Behar Chen Well Orion & Co; Ephraim Friedman – Fischer Behar Chen Well Orion & Co; Moran Friedman – Fischer Behar Chen Well Orion & Co; Sharon Klein-Manbar – Fischer Behar Chen Well Orion & Co; Yuval Peled – Fischer Behar Chen Well Orion & Co; Sharona Haim Pour – Abramovich – Fischer Behar Chen Well Orion & Co; Ziv Schwartz – Fischer Behar Chen Well Orion & Co; Anat Shavit – Fischer Behar Chen Well Orion & Co; Ben Strauss – Fischer Behar Chen Well Orion & Co; Raz Tepper – Fischer Behar Chen Well Orion & Co; Hila Zackay – Fischer Behar Chen Well Orion & Co;

Law Firms: Fischer & Partner; Fischer Behar Chen Well Orion & Co;

Clients: Luminera Derm ;

Author: Michael Patrini.